Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,608 signal articles · 73 in last 24h · 122,664 total before filter · latest 1h ago
73last 24h
1235last 7d
205● bullish (7d)
146● bearish (7d)
205publishers
AllMacro198Earnings415M&A98Regulatory24Product12Analyst10
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?
Simply Wall St.15d agobullish
Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?

Halozyme earnings beat and guidance hike reshape the story Halozyme Therapeutics (HALO) just put fresh numbers on the table, reporting second quarter 2026 results, raising full year revenue guidance and updating progress on its share repurchase programs. For the quarter ended June 30, 2026, revenue was reported at US$481 million compared with US$325.72 million for the same period a year earlier. Net income for the quarter was US$229.91 million compared with US$165.16 million a year ago. Basic...

What Do MARA Holdings (MARA) Board Changes And Losses Mean For Its AI Pivot?
Simply Wall St.15d agoneutral
What Do MARA Holdings (MARA) Board Changes And Losses Mean For Its AI Pivot?

MARA Holdings (NasdaqCM:MARA) announced major boardroom changes as it pushes further into AI focused infrastructure and away from a pure bitcoin mining profile. Two directors resigned and were immediately replaced by industry figures with backgrounds in power and hyperscale data centers to support the company’s new direction. The board reshuffle came alongside the release of quarterly results that showed a substantial net loss and plans to expand power availability and AI capacity. These...

Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update
Simply Wall St.15d agobullish
Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update

Abbott Laboratories buyback update Abbott Laboratories (ABT) has completed a share repurchase tranche that saw the company buy back 14,015,097 shares for about US$1.35b, including 11,599,094 shares between April and June 2026. See our latest analysis for Abbott Laboratories. Abbott Laboratories shares trade at US$107.81 and have gained 27.86% over the past 90 days, while the year-to-date share price return is down 13.19% and the 1-year total shareholder return is down 17.86%. This points to...

Cheniere Energy Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Cheniere Energy Q2 Earnings Call Highlights

Cheniere Energy (NYSE:LNG) raised its 2026 financial outlook for a second consecutive quarter, citing higher production, stronger marketing margins and optimization activity as global LNG markets faced supply disruption tied to constrained flows through the Strait of Hormuz. The company reported se

Eli Lilly and Company Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly and Company (NYSE:LLY) reported 48% revenue growth in the second quarter of 2026, driven primarily by continued demand for its cardiometabolic medicines MOUNJARO and ZEPBOUND, while raising its full-year revenue and earnings guidance. Chair and CEO Dave Ricks said the company delivered gr

Centrus Energy Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Centrus Energy Q2 Earnings Call Highlights

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Google shutting down a popular feature after 10 years
TheStreet15d agoneutral
Google shutting down a popular feature after 10 years

More than a year after announcing plans to phase it out, Google is finally moving ahead with a major change that will affect millions of consumers. The familiar tool has been part of people's daily routines for years, helping with everything from simple questions and reminders to controlling ...

Bank of America revamps Apple stock price target after earnings
TheStreet15d agoneutral
Bank of America revamps Apple stock price target after earnings

ChatGPT went from generating roughly $10 million a month on Apple's App Store in Jan. 2024 to more than $275 million in July 2026. Apple did not build ChatGPT. It does not train it, run it, or market it. But every time someone subscribes, Apple collects a commission. That dynamic is playing out ...

American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus
Simply Wall St.15d agoneutral
American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus

American Express (AXP) has drawn fresh attention after completing a US$1.6b fixed income offering of preferred depository shares, giving investors another lens on the company alongside its common stock performance and recent earnings commentary. See our latest analysis for American Express. Against this backdrop, American Express shares trade at US$340.91, with a 90 day share price return of 7.87% even as the year to date share price return is down 8.54%. The 5 year total shareholder return...

DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat
Simply Wall St.15d agobullish
DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat

DaVita stock has climbed 69.6% over the past three years. After a recent pullback and a strong value score, the current price still raises questions about how much upside investors are actually paying for. Over the past 3 years, DaVita has returned 69.6%, which puts recent share price weakness in the context of a longer period of strong gains. Support for the valuation can come from expectations that DaVita benefits from growing demand for integrated kidney and metabolic care. Execution...

Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative?
Simply Wall St.15d agoneutral
Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative?

In early August 2026, Niagen Bioscience Inc. reported slightly lower quarterly sales and net income year on year, while also expanding access to its Tru Niagen® healthy‑aging NAD+ supplement via Walmart.com, initially offering 300 mg bottles in 30‑ and 90‑count formats. A new peer‑reviewed analysis in Aging Cell linked Niagen’s nicotinamide riboside supplementation to reduced muscle epigenetic age acceleration, adding scientific depth to its healthy‑aging positioning just as distribution...

Circle Internet Group (CRCL) Returns To Profit As Fair Value Doubts Linger
Simply Wall St.15d agoneutral
Circle Internet Group (CRCL) Returns To Profit As Fair Value Doubts Linger

Circle Internet Group (CRCL) just posted its second quarter 2026 results, shifting from a large loss a year ago to a profit, while also updating investors on progress with its Arc blockchain platform. See our latest analysis for Circle Internet Group. Circle Internet Group’s recent earnings swing to profit, Arc progress updates and regulatory milestones have come alongside a 1 day share price return of 5.36% and a 7 day share price return of 6.48%. However, the 1 year total shareholder return...

Karman Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Karman Q2 Earnings Call Highlights

Karman (NYSE:KRMN) reported record second-quarter fiscal 2026 results, citing strong demand across missile, defense, maritime and space markets, while raising its full-year revenue and adjusted EBITDA outlook. Revenue for the quarter totaled $182 million, up 58% from a year earlier and 20% sequenti

Kodiak Gas Services Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Kodiak Gas Services Q2 Earnings Call Highlights

Kodiak Gas Services (NYSE:KGS) reported record second-quarter adjusted EBITDA and raised portions of its 2026 outlook, as its contract compression business delivered higher pricing and margins and the company advanced plans to build a larger behind-the-meter power generation platform. The company r

Kyndryl Q1 Earnings Call Highlights
MarketBeat15d agoneutral
Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) reported fiscal first-quarter revenue of $3.6 billion, down 3% from a year earlier on both a reported and constant-currency basis, while maintaining its full-year outlook as it pursues growth in consulting, hyperscaler partnerships and AI-led modernization services. For the quarte